New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000627:therapeutic use*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000917:Antibody Formation; D006801:Humans; D007114:Immunization; D007117:Immunization, Secondary; D007167:Immunotherapy; D014612:Vaccines
D000276:Adjuvants, Immunologic; D014612:Vaccines; D000119:Acetylmuramyl-Alanyl-Isoglutamine